Kirsten L. Morton

Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement

James R. Shoblock, Natalie Welty, Leah Aluisio et al. · Psychopharmacology · 2010 · 159 citations

Life Sciences, Neuroscience, Pharmacology +15

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

James R. Shoblock, Natalie Welty, Diane Nepomuceno et al. · Psychopharmacology · 2009 · 52 citations

Life Sciences, Neuroscience, Pharmacology +14

Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X₇ Antagonists

Michael A. Letavic, Brian Lord, François Bischoff et al. · ACS Medicinal Chemistry Letters · 2013 · 48 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: Identification of candidates for clinical development

Michael A. Letavic, Leah Aluisio, John Atack et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists

Devin M. Swanson, Chandra Shah, Brian Lord et al. · European Journal of Medicinal Chemistry · 2009 · 21 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15